U.S. High Growth Tech and AI Stocks

Lumentum Holdings

Market Cap: US$4.5b

Manufactures and sells optical and photonic products in the Americas, the Asia-Pacific, Europe, the Middle East, and Africa.

Travere Therapeutics

Market Cap: US$1.8b

A biopharmaceutical company, identifies, develops, and delivers therapies to people living with rare kidney and metabolic diseases in the United States.

Alkami Technology

Market Cap: US$3.0b

Provides cloud-based digital banking solutions in the United States.

TG Therapeutics

Market Cap: US$5.3b

A commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally.

Alnylam Pharmaceuticals

Market Cap: US$32.7b

Alnylam Pharmaceuticals, Inc. discovers, develops, and commercializes therapeutics based on ribonucleic acid interference.

AVITA Medical

Market Cap: US$184.2m

Operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom.

Ascendis Pharma

Market Cap: US$9.1b

Operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Denmark, rest of Europe, North America, and internationally.

Ardelyx

Market Cap: US$866.1m

Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally.

Super Micro Computer

Market Cap: US$19.1b

Develops and sells high performance server and storage solutions based on modular and open architecture in the United States, Europe, Asia, and internationally.

Clene

Market Cap: US$22.7m

A clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics.

Blueprint Medicines

Market Cap: US$6.3b

A precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally.

Legend Biotech

Market Cap: US$5.8b

Through its subsidiaries, operates as a biopharmaceutical company that discovers, develops, manufactures, and commercializes novel cell therapies for oncology and other indications in the United States, China, and Europe.

Palantir Technologies

Market Cap: US$276.8b

Palantir Technologies Inc. builds and deploys software platforms for the intelligence community to assist in counterterrorism investigations and operations in the United States, the United Kingdom, and internationally.

CoreWeave

Market Cap: US$23.8b

Operates a cloud platform that provides scaling, support, and acceleration for GenAI.

Bitdeer Technologies Group

Market Cap: US$2.8b

Operates as a technology company for blockchain and computing.

Red Cat Holdings

Market Cap: US$536.7m

Provides products and solutions to drone industry in the United States.

Silence Therapeutics

Market Cap: US$174.7m

A biotechnology company, engages in the discovery and development of novel molecules incorporating short interfering ribonucleic acid (siRNA) to inhibit the expression of specific target genes in hematology, cardiovascular, and rare diseases.

Duos Technologies Group

Market Cap: US$85.6m

Designs, develops, deploys, and operates intelligent technology solutions in North America.

MeiraGTx Holdings

Market Cap: US$433.3m

A clinical stage genetics medicines company, focusing on developing treatments for patients with serious diseases.

Vanda Pharmaceuticals

Market Cap: US$232.8m

A biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs worldwide.

UroGen Pharma

Market Cap: US$478.5m

Engages in the development and commercialization of solutions for urothelial and specialty cancers.

Spotify Technology

Market Cap: US$132.9b

Provides audio streaming subscription services worldwide.

Nutanix

Market Cap: US$20.0b

Provides an enterprise cloud platform in North America, Europe, the Asia Pacific, the Middle East, Latin America, and Africa.

Workday

Market Cap: US$69.3b

Provides enterprise cloud applications in the United States and internationally.

Zscaler

Market Cap: US$36.1b

Operates as a cloud security company worldwide.

Exelixis

Market Cap: US$10.0b

An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.

RenovoRx

Market Cap: US$38.7m

A clinical-stage biopharmaceutical company, engages in the developing of targeted combination therapies to enhance therapeutic outcomes for cancer patients undergoing treatment.

ARS Pharmaceuticals

Market Cap: US$1.3b

A biopharmaceutical company, develops and commercializes treatments for severe allergic reactions.

Capricor Therapeutics

Market Cap: US$289.6m

A clinical-stage biotechnology company, engages in the development of transformative cell and exosome-based therapeutics for treating duchenne muscular dystrophy (DMD) and other diseases with unmet medical needs in the United States.

Gorilla Technology Group

Market Cap: US$297.8m

Provides solutions in security, network, business intelligence, and Internet of Things (IoT) technology in Taiwan and the United Kingdom.

ACADIA Pharmaceuticals

Market Cap: US$2.9b

A biopharmaceutical company, focuses on the development and commercialization of medicines for central nervous system (CNS) disorders and rare diseases in the United States.

OS Therapies

Market Cap: US$42.2m

A clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States.

TeraWulf

Market Cap: US$1.2b

Operates as a digital asset technology company in the United States.

Aldeyra Therapeutics

Market Cap: US$130.6m

A biotechnology company, discovers and develops therapies designed to treat immune-mediated and metabolic diseases.

Abeona Therapeutics

Market Cap: US$255.8m

A clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases.

TruGolf Holdings

Market Cap: US$11.1m

Through its subsidiary, engages in the development and sale of indoor golf simulator hardware under the TruGolf Nevada brand for residential and commercial markets in the United States.